Blog

120 Articles

Survivor Stories
August 22, 2019 • 3 Min

I’ll Never Stop Fighting

When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.

Dr. Theodore Hong
Research
August 1, 2019 • 4 Min

New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response

Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.

A yellow paper model of DNA helix against a dark background
Research
July 11, 2019 • 2 Min

Immunotherapy to Attack a Common Pancreatic Cancer Mutation

Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.

a hand holding a petri dish in a lab, in black and white
Research
April 24, 2019 • 2 Min

Immunotherapy for Advanced Pancreatic Cancer and Other Solid Tumors

Researchers are testing the use of tumor-infiltrating lymphocytes, a type of immunotherapy, against advanced pancreatic cancer.

electron microscope image of concentric circles formed by reactive ion etching
Research
March 29, 2019 • 2 Min

Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer

Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.

Dr. Vinod Balachandran
Research
March 13, 2019 • 5 Min

Pancreatic Cancer Exceptional Responders and the Immune System Link

Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.

A latex-gloved hand doing close lab work
Research
March 5, 2019 • 2 Min

Targeting Cancer-Associated Wasting With Experimental Immunotherapy

Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.

Pancreatic microbiome
Research
February 15, 2019 • 4 Min

Pancreatic Microbiome May Hold the Key To Better Treatment

Dr. Deirdre Cohen’s research into the pancreatic microbiome has found that gut bacteria may directly influence the effectiveness of immunotherapy.

pancreatic cancer long-term survivor Roy Vinke in the snow
Survivor Stories
February 12, 2019 • 4 Min

Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life

When standard treatment did not work for Roy Vinke, he had genomic profiling done. A mutation was found, changing his treatment plan.

A human epithelial cell (DNA in blue) with increased numbers of centrosomes (green) amid a sea of normal cells.
Research
January 14, 2019 • 2 Min

Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer

Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.

Dr. Allyson Ocean
Research
January 9, 2019 • 6 Min

Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019

Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.

Deirdre Cohen
Research
December 17, 2018 • 4 Min

Aiming to Improve Immunotherapy for Pancreatic Cancer

Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.

Pancreatic cancer patient Rob Babcock, holding his granddaughter, and surrounded by his family
Survivor Stories
November 9, 2018 • 7 Min

Life With Pancreatic Cancer and on Clinical Trials

After a pancreatic cancer diagnosis, former basketball coach and GM Rob Babcock realized his best chance was with clinical trials.

Clear flasks on a yellow background, filled with water colored blue, green, or red
Research
November 6, 2018 • 2 Min

Immunotherapy Combination Plus Radiation for Pancreatic Cancer

Researchers are testing two monoclonal antibodies approved to treat melanoma plus radiation as a treatment for pancreatic cancer.

Grayscale image of round lab containers with dark agar medium arranged in rows.
Research
October 16, 2018 • 2 Min

Finding a Safe Dose of a New Drug for Some Types of Solid Tumors

LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.